Adbry
Tralokinumab-ldrm · LEO Pharma Inc.
PRESCRIPTION ONLY (USA)Adbry ingredients
| Active ingredient | Strength |
|---|---|
| Tralokinumab | 150 mg/mL, 300 mg/2mL |
What Adbry is used for
Adbry is a specialist medicine (interleukin-13 antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Adbry
- Generic name
- Tralokinumab-ldrm
- Made by
- LEO Pharma Inc.
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Interleukin-13 Antagonist
- FDA approval
- Biologic licence (BLA) BLA761180
- On the US market since
- 2022
Official information
- Adbry prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Tralokinumab-ldrm)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Adbry?
Adbry (Tralokinumab-ldrm) is a specialist medicine made by LEO Pharma Inc., approved by the US FDA.
What are the ingredients of Adbry?
Adbry contains Tralokinumab (150 mg/mL, 300 mg/2mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA